Press release
Fondaparinux Market Report 2022: By Key Players, Trends, Size, Share and Forecast 2022-2028
The global fondaparinux market is estimated to grow at a CAGR of nearly 7.5% during the forecast period. Significant rise in the prevalence of arthritis is primarily driving the global fondaparinux market. As per the Centers for Disease Control and Prevention (CDC), by 2040, the number of adults aged 18 years and over in the US with doctor-diagnosed arthritis is estimated to rise 49% to 78.4 million (25.9% of the estimated total US adult population), compared to 54.4 million adults in 2013-2015. Additionally, as per the Versus Arthritis, in UK, musculoskeletal conditions including arthritis and back pain affected nearly 18.8 million people in 2017.A full report of Fondaparinux Market is available at: https://www.omrglobal.com/industry-reports/fondaparinux-market
Osteoarthritis is the most common form of arthritis that are affecting millions of people globally. Globally, over 200 million women suffer from osteoporosis. 1 in 3 postmenopausal women has osteoporosis, which increases with age. Therefore, increasing prevalence of geriatric population is also a major cause for the rising incidences of osteoarthritis. As per the United Nations (UN), by 2050, 1 in 6 people globally will be more than the age of 65, increased from 1 in 11 in 2019. In 2019, 703 million people were aged 65 years or over globally, which is expected to double to 1.5 billion in 2050.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/fondaparinux-market
Osteoporosis commonly affects joints in hips, knees, spine, and hands, which results in the increasing number of hip and knee replacements. As per the Canadian Institute for Health Information (CIHI), in 2017-2018, 70,502 knee replacements and 58,492 hip replacements were performed in Canada. This shows a rise of 17.0% and 17.4%, respectively, over the last 5 years. According to the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR), there were a total of 242,629 cases registered to NJR during 2016/2017. It has shown a significant rise of over 20,000 joint replacement procedures than the previous year. This, in turn, is contributing to the adoption of fondaparinux to prevent deep vein thrombosis (blood clot) after the procedure.
Fondaparinux is used for the treatment of severe blood clots in the lungs or legs. It is often utilizing with another blood thinner drugs (warfarin). If blood clots are untreated, it can travel to the brain, heart, or lungs, causing serious breathing problems, stroke, or heart attack. Fondaparinux is further used for the prevention of blood clots after some procedures with an increased risk of blood clots, including knee and hip replacements, abdominal surgery, and hip fracture. Fondaparinux works similarly like heparin that blocks the activity of some clotting substances in the blood. However, fondaparinux has a longer half-life than heparin and does not interact with platelets. This, in turn, is contributing to the growth of the global fondaparinux market.
Global Fondaparinux Market- Segmentation
By Product Type
• Branded
• Generics
Fondaparinux Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Apicore LLC
• Aurobindo Pharma Ltd.
• Cadila Healthcare Ltd. (CHL)
• Dr Reddy's Laboratories Ltd.
• GlaxoSmithKline plc
• Italfarmaco S.p.A.
• Mylan N.V.
• Sandoz International GmbH
• ScinoPharm Taiwan, Ltd.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fondaparinux Market Report 2022: By Key Players, Trends, Size, Share and Forecast 2022-2028 here
News-ID: 2634279 • Views: …
More Releases from Orion Market Research

Drone Battery Market Comprehensive Research Study, Business Overview and Regiona …
The global drone battery market was valued at approximately USD 8.07 billion in 2024 and is projected to reach around USD 42.32 billion by 2034, growing at a compound annual growth rate (CAGR) of 18.02% from 2025 to 2034.
Drone Battery Market Overview
The drone battery market is experiencing significant growth, driven by the increasing adoption of drones across various sectors such as agriculture, logistics, defense, and media. These batteries…

Aviation Connectors Market By Application Analysis, Regional Outlook, Competitiv …
The global aviation connectors market was valued at approximately USD 5.6 billion in 2024 and is projected to reach around USD 11.42 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.14% from 2025 to 2034.
Aviation Connectors Market Overview
The aviation connectors market is experiencing robust growth, driven by the increasing demand for advanced avionics systems and the expansion of both commercial and military aircraft fleets.…

Industrial Wastewater Treatment Chemicals Market Development, Industry Trends, D …
The global industrial wastewater treatment chemicals market was valued at approximately USD 19.06 billion in 2024 and is projected to reach around USD 23.6 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033.
Industrial Wastewater Treatment Chemicals Market Overview
The global industrial wastewater treatment chemicals market is witnessing significant growth driven by increasing industrialization, stringent environmental regulations, and the growing need for sustainable water management. The…

Electronic Adhesives Market Development, Industry Trends, Demand and Growth Anal …
The global Electronic Adhesives Market was valued at approximately USD 5.11 billion in 2024 and is projected to reach USD 8.52 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5.6% between 2025 and 2033.
Electronic Adhesives Market Overview
The Electronic Adhesives Market is witnessing steady growth, driven by increased adoption of miniaturized electronics, EV components, and consumer gadgets requiring robust bonding, encapsulation, and thermal management. Key…
More Releases for Fondaparinux
Fondaparinux Market Expecting Huge Demand in Upcoming Years
The Fondaparinux Market 2025 Report makes available the current and future technical and financial analysis of the industry. It is one of the most comprehensive and important additions to the USD Analytics Market archive of market research studies. It offers detailed research and analysis of key aspects of the global Fondaparinux market. This global report explores the key factors affecting the growth of the dynamic Fondaparinux market, including the demand-supply…
Global Fondaparinux Sodium Market Imapct of AI and Automation
Fondaparinux Sodium Market Impact of AI and Automation
The global Fondaparinux Sodium market was valued at approximately USD 1.2 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of around 7.5% through the forecast period. This growth trajectory is driven by increasing demand for advanced anticoagulant therapies and a rising prevalence of thromboembolic disorders. The market's expansion is further supported by the growing adoption of…
Global Fondaparinux Market Growth, Size, Report & Forecast to 2020-2026
The global fondaparinux market is estimated to grow at a CAGR of nearly 7.5% during the forecast period. Significant rise in the prevalence of arthritis is primarily driving the global fondaparinux market. As per the Centers for Disease Control and Prevention (CDC), by 2040, the number of adults aged 18 years and over in the US with doctor-diagnosed arthritis is estimated to rise 49% to 78.4 million (25.9% of the…
Fondaparinux Industry : Market | Size | Analysis | Share | Outlook to 2025
Fondaparinux Industry Report has been prepared based on an in-depth market analysis with inputs from industry experts.
The report provides key statistics on the market status of the Fondaparinux Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Global Fondaparinux Market focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost,…
Global Fondaparinux Market 2016 - Reliable Biopharmaceutical, Aspen, Apotex, GSK …
Global Fondaparinux market Report offers decisive insights into the overall Fondaparinux industry along with the market dimensions and evaluation for the duration 2016 to 2021. The forenamed research study covers extensive analysis of various Fondaparinux industry segments based on the type of applications, type of product Components and services, and different geographical regions.
Fondaparinux market, an injectable blood thinner that fights clots in the legs (deep vein thrombosis) and lungs…
Global Fondaparinux Market 2017 - Reliable Biopharmaceutical, Aspen, Apotex, GSK …
Global Fondaparinux market Report offers decisive insights into the overall Fondaparinux industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Fondaparinux industry segments based on the type of applications, type of product Components and services, and different geographical regions.
Fondaparinux, an injectable blood thinner that fights clots in the legs (deep vein thrombosis) and lungs (pulmonary…